InvestorsHub Logo
Followers 1321
Posts 26906
Boards Moderated 6
Alias Born 12/10/2012

Re: None

Monday, 10/18/2021 2:44:14 PM

Monday, October 18, 2021 2:44:14 PM

Post# of 47
$VTYX: $125Mlly IPO coming...........


https://ventyxbio.com/


We are a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders.

Our clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions.




GO $VTYX
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTYX News